In a recent meta-analysis Koopman et al reported that the pooled risk estimate of incident type 2 diabetes for GAD65 antibody positivity, compared with GAD65 antibody negativity, was 3.36 (95% CI 1.9, 5.9) [20]. The gene discussed is GAD2; the disease is type 2 diabetes mellitus.